Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
717 studies found for:    Open Studies | "Prostatic Diseases"
Show Display Options
Rank Status Study
1 Recruiting Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia
Conditions: Prostatic Hyperplasia, Benign;   Prostatic Hypertrophy, Benign;   Genital Diseases, Male;   Lower Urinary Tract Symptoms;   Prostatic Diseases
Interventions: Procedure: Prostatic Arterial Embolization;   Procedure: Sham procedure
2 Recruiting MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
Conditions: Prostatic Neoplasms;   Genital Neoplasms, Male;   Prostatic Diseases
Intervention:
3 Not yet recruiting A Prospective Trial of Povidone-iodine Suppository Before Transrectal Ultrasound Guided Prostate Biopsy
Conditions: Infection;   Prostatic Diseases;   Misadventure During Aspirating Needle Biopsy
Intervention: Drug: Povidone-Iodine
4 Recruiting Molecular Studies and Clinical Correlations in Human Prostatic Disease
Condition: Prostate Cancer
Intervention:
5 Recruiting In Vivo Dosimetry During Prostate Cancer Radiotherapy
Condition: Prostate Disease
Intervention: Device: Plastic Scintillation Detectors
6 Unknown  Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients
Condition: Prostate Cancer
Intervention: Biological: PEP-223/CoVaccine HT
7 Recruiting Radiotherapy vs Observation for CRPC
Condition: Hormone Refractory Prostate Cancer
Intervention:
8 Recruiting Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Metastatic Prostate Cancer;   Androgen-independent Prostate Cancer;   Recurrent Prostate Cancer
Intervention: Drug: onapristone
9 Unknown  High-Intensity Focused Ultrasound Ablation in Treating Patients With Progressive Prostate Cancer
Condition: Prostate Cancer
Interventions: Other: pharmacological study;   Other: questionnaire administration;   Procedure: assessment of therapy complications;   Procedure: high-intensity focused ultrasound ablation;   Procedure: quality-of-life assessment
10 Recruiting First-in-man Dose Escalation Study of BAY2010112 in Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Biological: BAY2010112
11 Recruiting Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate
Conditions: Prostate Adenocarcinoma;   Prostate Cancer;   High Risk Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Abiraterone Acetate;   Drug: Prednisone;   Drug: Leuprolide Acetate
12 Recruiting Intrathecal Morphine in Robot-assisted Prostatectomy
Condition: Prostatic Neoplasms
Interventions: Drug: The intravenous patient-controlled analgesia;   Drug: The intrathecal morphine injection
13 Recruiting BIOPROP20: Biologically Optimised IMRT for Prostate Radiotherapy Hypofractionated Radiotherapy With Intra-prostatic Boosts to Tumour Nodules in Men With Intermediate and High Risk Prostate Cancer
Condition: Prostate Cancer
Intervention: Radiation: Hypofractionated IMRT boost Radiotherapy
14 Recruiting TRT on BPH Hypoganadal MetS Patients. Florence-PROTEST
Conditions: Prostatic Hyperplasia;   Lower Urinary Tract Symptoms;   Hypogonadism
Interventions: Drug: Testosterone gel 2%;   Other: Placebo
15 Recruiting Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence
Condition: Prostate Cancer
Intervention: Other: blood draw
16 Recruiting Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Hormone-Resistant Prostate Cancer;   Recurrent Prostate Carcinoma;   Stage IV Prostate Cancer
Interventions: Biological: Sipuleucel-T;   Drug: Tasquinimod;   Other: Laboratory Biomarker Analysis
17 Recruiting Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Cabazitaxel;   Radiation: Intensity Modulated Radiation Therapy (IMRT);   Drug: Anti-Androgen Therapy: Bicalutamide;   Genetic: Luteinizing Hormone-Releasing Hormone (LHRH) Agonist
18 Not yet recruiting Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Biological: anti-PSMA monoclonal antibody MDX1201-A488;   Procedure: robot-assisted laparoscopic surgery;   Other: diffuse optical imaging;   Other: pharmacological study
19 Unknown  Choline-PET for Evaluating the Incidence of Nodal Metastases Among Newly Diagnosed Patients of Prostate Cancer
Condition: Prostate Cancer
Intervention: Other: Choline-PET
20 Recruiting Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: PROSTVAC-F/TRICOM;   Biological: PROSTVAC-V/TRICOM;   Drug: Enzalutamide (Xtandi)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years